MARKET

LMAT

LMAT

LeMaitre
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.89
-0.17
-0.63%
Closed 16:00 05/29 EDT
OPEN
26.97
PREV CLOSE
27.06
HIGH
27.24
LOW
26.16
VOLUME
182.48K
TURNOVER
--
52 WEEK HIGH
38.64
52 WEEK LOW
18.76
MARKET CAP
542.60M
P/E (TTM)
30.49
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LMAT stock price target is 30.00 with a high estimate of 34.00 and a low estimate of 25.00.

EPS

LMAT News

More
LeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference
GlobeNewswire · 3d ago
3 Medical-Supply Stocks You Should Own Besides Medtronic
MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.
Motley Fool · 05/24 11:05
Edited Transcript of LMAT earnings conference call or presentation 30-Apr-20 9:00pm GMT
Thomson Reuters StreetEvents · 05/20 14:50
LeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference
BURLINGTON, Mass., May 12, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare.
GlobeNewswire · 05/12 14:35
Trump Pushes for US-Made Medical Products: 4 Winners
Zacks · 05/05 13:36
Stifel Maintains Hold on LeMaitre Vascular, Lowers Price Target to $25
Stifel maintains LeMaitre Vascular (NASDAQ:LMAT) with a Hold and lowers the price target from $30 to $25.
Benzinga · 05/04 13:19
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/02 22:13
LeMaitre Vascular (LMAT) Q1 2020 Earnings Call Transcript
Motley Fool · 05/02 03:01

Industry

Advanced Medical Equipment & Technology
+1.42%
Healthcare Equipment & Supplies
+1.33%

Hot Stocks

Symbol
Price
%Change

About LMAT

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.
More

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.